DexCom, Inc. (DXCM) — Analysis Summary
DexCom, Inc. (DXCM) has a market cap of $28.45B with year-over-year revenue growth of +15.6%. Net margin stands at 17.9%. The stock trades at a P/E ratio of 30.6.
Key Takeaways
- Revenue changed +15.6% year-over-year
- Net margin of 17.9%
- P/E ratio of 30.6
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, DXCM posted revenue growth of +15.6% and trades at a P/E of 30.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.